(GPAT) GP-Act III Acquisition - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: (N/A)

GPAT EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of GPAT over the last 5 years for every Quarter.

GPAT Revenue

This chart shows the Revenue of GPAT over the last 5 years for every Quarter.

GPAT: Mergers, Acquisitions, Business Combinations

GP-Act III Acquisition Corp. is a special purpose acquisition company (SPAC) that aims to merge with or acquire a business, facilitating its entry into the public market. As a SPAC, it provides a unique opportunity for investors to participate in the growth of a company that has not yet been identified. With its base in New York, the company was initially known as GP Investments Acquisition Corp. II before rebranding in November 2020.

The companys strategy involves identifying a suitable target for a business combination, leveraging its expertise and resources to facilitate a successful merger or acquisition. As a blank-check company, GP-Act III Acquisition Corp.s success hinges on its ability to identify and capitalize on a promising investment opportunity, ultimately generating returns for its shareholders.

Analyzing the technical data, we observe that the stock has been exhibiting a relatively stable trend, with the short-term and long-term moving averages converging. The Average True Range (ATR) indicates low volatility, suggesting a period of consolidation. Based on the , a potential breakout above the 52-week high of 10.45 could signal a bullish trend, with a potential target of 10.60.

From a fundamental perspective, the companys market capitalization stands at $374.47 million, with a price-to-earnings ratio of 30.65. The return on equity is 4.14%, indicating a relatively modest level of profitability. By combining the with the , we can forecast that if the company successfully completes a merger or acquisition, the stock price could experience a significant surge, potentially reaching $12.00 within the next 6-12 months, driven by increased investor confidence and growth prospects.

However, if the company fails to identify a suitable target or complete a business combination within the allotted timeframe, the stock price may experience a decline, potentially falling to $9.50 or lower. As such, investors should closely monitor the companys progress and adjust their strategies accordingly.

Additional Sources for GPAT Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

GPAT Stock Overview

Market Cap in USD 380m
Sector Financial Services
Industry Shell Companies
GiC Sub-Industry Diversified Financial Services
IPO / Inception 2024-07-01

GPAT Stock Ratings

Growth Rating 47.4
Fundamental 8.74
Dividend Rating 0.0
Rel. Strength -12.6
Analysts -
Fair Price Momentum 10.01 USD
Fair Price DCF -

GPAT Dividends

Currently no dividends paid

GPAT Growth Ratios

Growth Correlation 3m 97.5%
Growth Correlation 12m 98.7%
Growth Correlation 5y 98.7%
CAGR 5y 6.01%
CAGR/Max DD 5y 8.82
Sharpe Ratio 12m -1.61
Alpha 1.72
Beta 0.012
Volatility 3.97%
Current Volume 6.6k
Average Volume 20d 6.1k
What is the price of GPAT shares?
As of June 16, 2025, the stock is trading at USD 10.59 with a total of 6,648 shares traded.
Over the past week, the price has changed by +0.28%, over one month by +0.95%, over three months by +3.12% and over the past year by +6.01%.
Is GP-Act III Acquisition a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, GP-Act III Acquisition is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.74 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GPAT is around 10.01 USD . This means that GPAT is currently overvalued and has a potential downside of -5.48%.
Is GPAT a buy, sell or hold?
GP-Act III Acquisition has no consensus analysts rating.
What are the forecasts for GPAT share price target?
According to our own proprietary Forecast Model, GPAT GP-Act III Acquisition will be worth about 10.8 in June 2026. The stock is currently trading at 10.59. This means that the stock has a potential upside of +2.08%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 10.8 2.1%